Portal de Periódicos da CAPES

Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression

2002; Alan R. Liss, Inc.; Volume: 39; Issue: 1 Linguagem: Inglês

10.1002/mpo.10050

1096-911X

Natalie Kerr, Yang‐Hyun Chun, Kankatsu Yun, Rosemary Heathcott, Anthony E. Reeve, Michael Sullivan,

RNA modifications and cancer

Medical and Pediatric OncologyVolume 39, Issue 1 p. 52-54 Brief Report Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression Natalie J. Kerr MSc (Hons), Natalie J. Kerr MSc (Hons) Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandSearch for more papers by this authorYang-Hyun Chun DDS, PhD, Yang-Hyun Chun DDS, PhD Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandSearch for more papers by this authorKankatsu Yun FRCPA, PhD, Kankatsu Yun FRCPA, PhD Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandSearch for more papers by this authorRosemary W. Heathcott BSc, Rosemary W. Heathcott BSc Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandSearch for more papers by this authorAnthony E. Reeve PhD, Anthony E. Reeve PhD Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandSearch for more papers by this authorMichael J. Sullivan FRACP, PhD, Corresponding Author Michael J. Sullivan FRACP, PhD [email protected] Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandCancer Genetics Laboratory, Department of Biochemistry, University of Otago, P.O. Box 56, Dunedin, New Zealand.Search for more papers by this author Natalie J. Kerr MSc (Hons), Natalie J. Kerr MSc (Hons) Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandSearch for more papers by this authorYang-Hyun Chun DDS, PhD, Yang-Hyun Chun DDS, PhD Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandSearch for more papers by this authorKankatsu Yun FRCPA, PhD, Kankatsu Yun FRCPA, PhD Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New ZealandSearch for more papers by this authorRosemary W. Heathcott BSc, Rosemary W. Heathcott BSc Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandSearch for more papers by this authorAnthony E. Reeve PhD, Anthony E. Reeve PhD Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandSearch for more papers by this authorMichael J. Sullivan FRACP, PhD, Corresponding Author Michael J. Sullivan FRACP, PhD [email protected] Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New ZealandCancer Genetics Laboratory, Department of Biochemistry, University of Otago, P.O. Box 56, Dunedin, New Zealand.Search for more papers by this author First published: 19 May 2002 https://doi.org/10.1002/mpo.10050Citations: 48AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume39, Issue1July 2002Pages 52-54 RelatedInformation